8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser: Rathbones Group Plc
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
 
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offeree
Eleco Plc
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e)   Date position held/dealing undertaken:
        For an opening position disclosure, state the latest practicable date prior to the disclosure
18/09/2026
(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
        If it is a cash offer or possible cash offer, state “N/A”
No

2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

1p Ordinary Shares
  Interests Short positions
  Number % Number %
(1)   Relevant securities owned and/or controlled: 1,157,620 1.37%    
(2)   Cash-settled derivatives:

       
(3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        

        TOTAL:

1,157,620 1.37%    

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)      Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchase/sale

Number of securities Price per unit
1p Ordinary Shares Sale 850 229.36p

(b)        Cash-settled derivative transactions

Class of relevant security Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit
         

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
e.g. American, European etc.
Expiry date Option money paid/ received per unit
               

(ii)        Exercise

Class of relevant security Product description
e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit
         

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing
e.g. subscription, conversion
Details Price per unit (if applicable)
1p Ordinary Shares      

4.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)   the voting rights of any relevant securities under any option; or
(ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached? No

Date of disclosure: 21/09/2026
Contact name: Lydia Cotterill – Compliance Department
Telephone number: 0151 237 1176

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

ANNOUNCEMENT

A.P. Møller – Mærsk A/S – Transactions in connection with share buy-back program
On 5 February 2026, A.P. Møller – Mærsk A/S (the “Company”) announced a share buy-back program of up to DKK 6.3bn (around USD 1bn) to be executed over a period of 12 months. The second phase of the share buy-back program will run from 13 August 2026 up to 29 January 2027. The shares to be acquired will be limited to a total market value of DKK 3.15 billion (around USD 500m).

The share buy-back program will be executed under EU Commission Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the “Safe Harbour Regulation”).

The following transactions have been made under the program in the period 14 September to 18 September 2026:

  Number of A shares Average purchase price A shares, DKK Transaction value,
A shares, DKK
Accumulated, last announcement 44,198   726,177,680
14 September 2026 250 22,402.2400 5,600,560
15 September 2026 250 22,309.6800 5,577,420
16 September 2026 250 21,980.9600 5,495,240
17 September 2026 250 21,902.6400 5,475,660
18 September 2026 250 21,779.2000 5,444,800
Total 14-18 September 2026 1,250   27,593,680
Accumulated in the second phase of the program 7,200   151,416,990
Accumulated under the program 45,448   753,771,360
  Number of B shares Average purchase price B shares, DKK Transaction value,
B shares, DKK
Accumulated, last announcement (market and the Foundation) 176,792   2,972,327,550
14 September 2026 877 23,259.3957 20,398,490
15 September 2026 877 23,164.6294 20,315,380
16 September 2026 877 22,791.0718 19,987,770
17 September 2026 877 22,712.4173 19,918,790
18 September 2026 877 22,530.9350 19,759,630
Total 14-18 September 2026 4,385   100,380,060
Bought from the Foundation* 615 22,891.6898 14,078,389
Accumulated in the second phase of the program (market and the Foundation) 28,800   628,917,724
Accumulated under the program (market and the Foundation) 181,792   3,086,785,999

*) According to a separate agreement, A.P. Møller og Hustru Chastine Mc-Kinney Møllers Familiefond (the Foundation) participates on a pro rata basis to the shares purchased in the share buy-back program.

With the transactions stated above, the Company owns a total of 45,448 A shares and 241,430 B shares as treasury shares, corresponding to 1.95% of the share capital. Details of each transaction are included as appendix.

Copenhagen, 21 September 2026

Contact persons:
Head of Investor Relations, Martin Dunwoodie, tel. +45 3363 3484
Head of Media Relations, Jesper Lov, tel. +45 6114 1521

Page 1 of 1

Attachments

WAM-V unmanned surface vessels integrated with U.S. command and control and supported training for the U.S. Navy and Marine Corps personnel in autonomous operations during the multinational exercise in Portugal

MONROE TOWNSHIP, N.J., Sept. 21, 2026 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (“OPT” or the “Company”) (NYSE American: OPTT), a leader in maritime operational infrastructure and autonomous ocean systems, today announced that three classes of its WAM-V® unmanned surface vessels operated across multiple mission sets at REPMUS 2026, the multinational robotic experimentation exercise led by the Portuguese Navy in close collaboration with NATO, the University of Porto, and the European Defense Agency (EDA).

The annual exercise brings together military forces, academia, and technology companies from across the globe to test, develop, and integrate unmanned systems into real-world maritime operations. The exercise is designed to drive multi-domain interoperability among allied maritime unmanned systems under realistic operational conditions.

Over the course of the exercise, OPT vessels supported five mission sets: rapid environmental assessment; mine countermeasures; harbor security; surveillance and reconnaissance; and above-water warfare.

The WAM-V 8 conducted rapid environmental assessment, delivering bathymetric survey data in amphibious surf zones in support of landing and raiding forces, and was beach-launched ahead of amphibious operations. The WAM-V 16 supported mine countermeasures tasking in the beach and harbor approaches for harbor security. The `WAM-V 22 operated in above-water warfare, including surface target identification under operational tasking, and conducted intelligence, surveillance and reconnaissance.

OPT vessels integrated with U.S. command and control during the exercise and were the only U.S. unmanned surface vessels to do so. A WAM-V 22 was also employed to train U.S. Navy and Marine Corps personnel in basic autonomous operations.

“The test of an unmanned system isn’t whether it performs at a demonstration. It’s whether an operational commander will task it alongside everything else he’s responsible for,” said Jason Weed, Chief Operating Officer of OPT. “At REPMUS, our vessels weren’t on display; they were given work. Three different classes, five different missions, inside someone else’s operational picture. That’s the capability our customers are actually buying.”

For more information about Ocean Power Technologies, visit www.OceanPowerTechnologies.com.

ABOUT OCEAN POWER TECHNOLOGIES

OPT provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets, including Merrows™, which provides AI capable seamless integration of Maritime Domain Awareness Systems across platforms. Our PowerBuoy® platforms provide clean and reliable electric power and real-time data communications for remote maritime and subsea applications. We also provide WAM-V® unmanned surface vessels (USVs) and marine robotics services. The Company’s headquarters is in Monroe Township, New Jersey, with an additional office in Richmond, California. To learn more about OPT’s products, services and solutions, visit www.OceanPowerTechnologies.com.

FORWARD-LOOKING STATEMENTS

This release may contain forward-looking statements that are within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by certain words or phrases such as “may”, “will”, “aim”, “will likely result”, “believe”, “expect”, “will continue”, “anticipate”, “estimate”, “intend”, “plan”, “contemplate”, “seek to”, “future”, “objective”, “goal”, “project”, “should”, “will pursue” and similar expressions or variations of such expressions. These forward-looking statements reflect the Company’s current expectations about its future plans and performance. These forward-looking statements rely on a number of assumptions and estimates that could be inaccurate and subject to risks and uncertainties, including the Company’s ability to support maritime missions, integrate WAM-V platforms with customer command and control systems, and deliver operator training and customer services, the conversion of potential customers to contracts and the realization of the potential revenue thereunder. Actual results could vary materially from those anticipated or expressed in any forward-looking statement made by the Company. Please refer to the Company’s most recent Forms 10-Q and 10-K and subsequent filings with the U.S. Securities and Exchange Commission for further discussion of these risks and uncertainties. The Company disclaims any obligation or intent to update the forward-looking statements in order to reflect events or circumstances after the date of this release.

Contact Information

Investors: 203-561-6945 or investorrelations@oceanpowertech.com

Media: 609-730-0400 x402 or MediaRelations@oceanpowertech.com

LAS VEGAS, Nevada, Sept. 21, 2026 (GLOBE NEWSWIRE) — High Roller Technologies, Inc. (“High Roller” or the “Company”) (NYSE: ROLR), a publicly traded online gaming and prediction markets company, today announced that Chief Executive Officer Seth Young will participate in PREDICT 2026, The Prediction Markets Conference™, taking place October 6–7, 2026, at the New York Marriott Marquis in New York City. Young will participate in the following panel discussion:

Panel: The Future of Interactive Gaming: Innovation, Technology & Scale
Date: Tuesday, October 6, 2026
Time: 2:15–2:55 p.m. Eastern Time
Participants:

  • Seth Young, Chief Executive Officer, High Roller Technologies
  • Travis Geiger, Co-Founder, WagerWire
  • Dustin Gouker, Founder, Event Horizon
  • Dan Wallach, Gaming Law and Sports Betting Attorney, Wallach Legal US

As prediction markets gain traction, the panel will examine the technology, market-making, liquidity and payment infrastructure supporting new sectors at scale, along with the use of AI and data analytics to improve personalization and engagement and emerging opportunities across entertainment, esports, creator-driven markets and live events.

Young will also be available for one-on-one meetings during the conference. Investors, analysts and other interested parties may request a meeting through the conference’s one-on-one meeting platform.

Registration: Details are available on the PREDICT 2026 conference website.

About High Roller Technologies, Inc.

High Roller Technologies, Inc. (NYSE: ROLR) is a publicly traded online gaming and prediction markets company, known for its innovative casino brands High Roller and Fruta, and its prediction markets brand, ROLR. The Company delivers cutting-edge real-money consumer facing products that are intuitive and user-friendly. With a diverse portfolio of over 6,000 premium online casino games from more than 90 leading game providers, High Roller Technologies offers an immersive and engaging gaming experience in the rapidly expanding multi-billion-dollar iGaming industry. As an award-winning operator, High Roller Technologies continues to redefine the future of market engagement through innovation, performance, and a commitment to excellence.

For more information, please visit the Company’s investor relations website and follow High Roller Technologies on X, Facebook, and LinkedIn.

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions, the commercial launch timing of the ROLR™ prediction markets platform. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the ability of the Company to successfully complete the closed beta on the anticipated timeline, risks related to platform stability, scalability and technical readiness, the regulatory environment applicable to prediction markets, the Company’s ability to attract and retain platform users, and general market and economic conditions and such factors as discussed throughout Part I, Item 1A. Risk Factors and Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2025, Part I. Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A. Risk Factors, of our quarterly report on Form 10-Q for the quarter ended June 30, 2026 and in our other filings with the Securities and Exchange Commission. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Contact
Investor Relations
ir@highroller.com
800-460-1039

COMPANY ANNOUNCEMENT NO 50/2026 – September 21, 2026

On August 17, 2026, Royal Unibrew announced a share buy-back program, cf. company announcement no. 44/2026.

The share buy-back program will be executed under EU Commission Regulation No. 596/2014 of the European Parliament and Council of April 16, 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the “Safe Harbour Regulation”). 

The share buy-back program is expected to be realized in the period from August 18, 2026, to December 8, 2026. The total transaction value of the share buy-backs in the period will not exceed DKK 300m.

The following transactions have been made under the program:

  Number of
Shares
Average purchase price DKK Transaction value, DKK
Accumulated, last announcement 172,848 427.09 73,821,189
September 14, 2026 7,000 421.02 2,947,146
September 15, 2026 8,000 420.86 3,366,918
September 16, 2026 8,000 420.63 3,365,061
September 17, 2026 8,000 420.65 3,365,227
September 18, 2026 12,000 414.88 4,978,513
Total accumulated under the program 215,848 425.50 91,844,054

With the transactions stated above Royal Unibrew owns a total of 1,998,436 shares, corresponding to 4.1% of the share capital. The total amount of shares in the company is 49,300,000, including treasury shares.

For further information please contact:
Flemming Ole Nielsen (Head of Investor Relations)
E-mail: Flemming.Nielsen@royalunibrew.com
Telephone: +45 25 41 68 04

Encl.

Attachments

DENVER, Sept. 21, 2026 (GLOBE NEWSWIRE) — (247marketnews.com) – NeOnc Technologies Holdings’ (NASDAQ: NTHI) NEO100 deserves attention; not just because its Phase 2a study has suddenly solved brain cancer, but because it is testing a different answer to one of the field’s oldest problems.

The disease is aggressive. Patients may have already undergone surgery, radiation and temozolomide. Once the tumor returns, treatment options narrow, and the central problem is not simply finding another molecule that can kill cancer cells. It is getting an effective amount of that molecule to the right place without creating unacceptable toxicity elsewhere.

Recurrent high-grade glioma is where oncology’s promises tend to collide with biology.

NEO100 is an intranasal formulation of purified perillyl alcohol. The Company’s basic proposition is straightforward: rather than asking a drug to cross the blood-brain barrier from the bloodstream, deliver it through the nose and attempt to reach the brain through the olfactory pathway. The approach turns drug delivery itself into part of the therapeutic strategy.

On August 12, 2026, NeOnc reported topline results from the Phase 2a portion of NEO100-01, an open-label study in patients with recurrent or progressive Grade III and Grade IV IDH1-mutant glioma. The 24-patient study reported six-month progression-free survival of 48.9%, compared with a 20% benchmark specified in the study design for standard of care. The Company reported a one-sided p-value of 0.0047. Median overall survival was 26.09 months, while overall survival at six months was 86.7%.

Those are attention-getting numbers and one of the next steps could be demonstrating that NEO100 works in a randomized trial and establish that nose-to-brain delivery is superior to conventional systemic treatment.

The Phase 2a study enrolled 24 patients. It was open-label and compared its primary endpoint with a prespecified historical benchmark rather than a concurrent randomized control group. The reported six-month PFS estimate also has a confidence interval of 26.3% to 68.1%, illustrating how much uncertainty remains around an estimate derived from such a small population.

That is precisely what makes the NEO100 story interesting. The experiment is testing two hypotheses at once. The first is therapeutic: can perillyl alcohol meaningfully control recurrent IDH1-mutant high-grade glioma? The second is logistical and biological: can intranasal delivery provide a practical way of getting a drug into the central nervous system?

The Second Question may Ultimately Prove as Important as the First

For decades, the blood-brain barrier has been treated as both a biological defense system and a drug-development obstacle. It protects the brain from potentially harmful substances circulating in the blood, but that protection also prevents many cancer drugs from reaching tumors at therapeutically useful concentrations. Researchers have pursued molecular engineering, nanoparticles, focused ultrasound, convection-enhanced delivery and other strategies to circumvent or temporarily alter the barrier.

An intranasal approach offers a different proposition. Instead of breaking the barrier down, it tries to exploit an anatomical route around it.

The attraction is obvious. A patient in the NEO100 program can self-administer the drug at home. The Company says the recommended regimen is intranasal dosing four times daily in 28-day cycles. The Phase 2a report said no major toxicities were observed and that adverse events were predominantly low-grade.

Home Administration matters in Oncology more than the Phrase Suggests

A treatment that requires hospitalization, infusion infrastructure or repeated invasive procedures carries a burden beyond its pharmacology. A treatment that can be administered by a patient at home potentially changes the practical economics and experience of therapy. For patients living with recurrent brain cancer, avoiding another procedure can be clinically meaningful even before the question of efficacy is settled.

The most intriguing detail in the August readout may be the distribution of outcomes rather than the headline PFS figure. NeOnc reported that five of the 24 patients remained on treatment at the time of the readout. One patient had an ongoing partial response beyond 114 days, while another patient was reported to have remained progression-free for roughly 19 months.

That kind of long tail is precisely what researchers will want to understand.

Is it evidence of a biologically distinct subgroup? Is IDH1 mutation status identifying patients unusually sensitive to the treatment? Is the apparent tail reproducible? Or does a small sample simply make unusual individual outcomes disproportionately visible?

NeOnc pointed to a biological rationale involving IDH1-mutant tumors, saying earlier Phase 1 experience had shown long-term survivors carrying an IDH1 mutation. That is an interesting hypothesis, but a hypothesis is not the same as a validated predictive biomarker.

The Next Stage Therefore Matters Enormously

NeOnc has said it intends to request a Type B meeting with the FDA to discuss a potential registrational path for NEO100 in recurrent IDH1-mutant high-grade glioma. The question for regulators will not simply be whether the Phase 2a result cleared its prespecified statistical benchmark. It will be whether the design, population, endpoint and magnitude of the observed effect provide an adequate foundation for the next development step.

That is where the distinction between a promising Phase 2a study and a medicine becomes unavoidable.

A successful oncology drug has to survive multiple forms of scrutiny: statistical, clinical, manufacturing, regulatory and practical. The more unusual the delivery mechanism, the more important it becomes to demonstrate not merely that patients received the drug, but that the delivery strategy produces clinically meaningful benefit.

There is also a Larger Lesson Here

Brain-cancer drug development often becomes a contest between elegant biology and brutal logistics. A molecule can look compelling in a laboratory and fail because insufficient drug reaches the tumor. A delivery technology can look ingenious and fail because the therapeutic payload is not sufficiently active. NEO100 is attempting to solve both problems with one strategy.

That is a high bar and the encouraging part is that the Phase 2a study appears to have generated a signal worth investigating.

The more interesting conclusion is that NEO100 has made the blood-brain barrier itself part of the clinical experiment.

If larger and better-controlled studies reproduce the signal, the significance could extend beyond perillyl alcohol or NeOnc. It would strengthen the case for intranasal delivery as a genuine CNS-development strategy.

The nose spray has not yet changed brain-cancer care, but it has, however, produced enough evidence to make the question worth asking seriously.

About 24/7 Market News

In today’s fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you’re an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247mnn.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.

This is a paid editorial communication intended for informational purposes only. 24/7 is compensated by NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. For further disclosure information, please click here. This should not be construed as financial or investment advice. Trading involves substantial risk; consult your financial advisor.

Important Editorial Note: 247 highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication. Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.

CONTACT:
24/7 Market News
Editor@247mnn.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.

TORONTO, Sept. 21, 2026 (GLOBE NEWSWIRE) — Osisko Critical Minerals Corporation (“OCMC” or the “Corporation“), a newly incorporated entity and a wholly-owned subsidiary of Osisko Metals Incorporated (“Osisko Metals“) (TSX: OM; OTCQX: OMZNF; FRANKFURT: 0B51), is pleased to announce an upsize of its previously announced “best efforts” private placement (the “Private Placement“) of special warrants of the Corporation (the “Special Warrants“), from aggregate gross proceeds of up to $100 million to up to $250 million.

Incoming CEO John Burzynski commented: “The decision to upsize our Private Placement from $100 million to $250 million is a result of overwhelming demand from investors for OCMC. This strong reception reflects confidence in our exploration portfolio and the significant opportunity we see in New Brunswick. We look forward to completing this upsized offering to capitalize this new venture and to advancing our aggressive exploration program on these highly prospective copper assets and our larger critical minerals strategy.”

The Private Placement is more particularly described in the news release of Osisko Metals dated September 16, 2026 titled “Osisko Critical Minerals Corporation Announces C$100 Million Private Placement of Special Warrants” (the “Prior News Release“). The Private Placement will be led by Canaccord Genuity Corp. (“Canaccord Genuity“), acting as lead agent and sole bookrunner, on behalf of a syndicate of agents (collectively, the “Agents“). All other terms of the Private Placement remain as described in the Prior News Release.

Bennett Jones LLP is acting as legal advisors to Osisko Metals in connection with the Private Placement. Peterson McVicar LLP is acting as legal advisors to OCMC in connection with certain corporate matters. Cassels Brock & Blackwell LLP is acting as legal advisors to the Agents in connection with the Private Placement.

Additional Information

There is no certainty that the Private Placement will be completed on the terms proposed, or at all. Completion of the Private Placement is subject to a number of conditions, including: completion of legal and tax structuring; completion of financial analysis; negotiation and execution of definitive documentation; and required regulatory approvals. There can be no assurance that any securities of the Corporation will be listed on any stock exchange.

About Osisko Critical Minerals Corporation

Osisko Critical Minerals Corporation is a newly incorporated Canadian mineral exploration company focused on the discovery and development of copper and critical minerals deposits. The Corporation’s principal assets are the Properties, comprising approximately 645 square kilometres of mineral claims in northern New Brunswick, Canada. The Properties include the NB Copper Project, which hosts large-scale exploration targets for bulk-tonnage copper deposits in a geological setting analogous to the nearby Gaspé Copper Project. OCMC is led by John Burzynski as Chief Executive Officer and is a wholly-owned subsidiary of Osisko Metals Incorporated pending completion of the Private Placement.

For further information on this news release, contact:

Don Njegovan, President
Email: info@osiskometals.com
Phone: (416) 500-4129

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation based on expectations, estimates and projections as at the date of this news release. Forward-looking information in this news release includes, but is not limited to, statements with respect to: the terms, timing, completion and outcome of the Private Placement, including the actual size of the Private Placement, the expected use of proceeds and the expected closing date; the completion of the related legal and tax structuring; the listing of any securities of the Corporation on any stock exchange; the future plans, objectives and business strategy of the Corporation, including with respect to the exploration and development of copper and critical minerals deposits; the Corporation’s exploration program on the Properties, including the NB Copper Project and the exploration targets thereon; the geological potential of the Properties, including the analogous geological setting to the nearby Gaspé Copper Project; and the anticipated role and leadership of the Corporation’s management team. Forward-looking information is based on certain assumptions and other factors, including: that the Private Placement will be completed on the terms described herein and in the Prior News Release; that required regulatory approvals will be obtained in a timely manner; that the Corporation will be able to execute on its business strategy and exploration plans; and that general market and economic conditions will not materially change. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Corporation to be materially different from those expressed or implied by such forward-looking information, including but not limited to: risks relating to the completion of the Private Placement; the inability to obtain required regulatory approvals; uncertainty regarding the listing of the Corporation’s securities on any stock exchange; risks inherent to mineral exploration activities, including the uncertainty of mineral resource estimates; changes in general economic, business and political conditions, including changes in the financial markets; fluctuations in commodity prices, including copper and other critical minerals prices; risks related to the early stage of the Corporation’s business and the Properties; and the other risks and uncertainties described in Osisko Metals’ public disclosure record on SEDAR+ (www.sedarplus.ca) under Osisko Metals’ issuer profile. For a more complete discussion of forward-looking information and the risks and assumptions related thereto, readers are referred to the Prior News Release and Osisko Metals’ public disclosure record on SEDAR+.

Although Osisko Metals believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Forward-looking information in this news release is not a guarantee of future performance and involves estimates, assumptions, risks and uncertainties (including those described above and in Osisko Metals’ public disclosure record on SEDAR+ (www.sedarplus.ca)). Actual results or events may differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on forward-looking information. Osisko Metals and the Corporation disclaim any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

ASML reports transactions under its current share buyback program

VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML’s current share buyback program.

Date Total repurchased shares Weighted average price Total repurchased value
14-Sep-26 89,000 €1,392.82 €123,960,829
15-Sep-26 65,000 €1,389.45 €90,314,231
16-Sep-26 60,000 €1,406.66 €84,399,882
17-Sep-26 47,500 €1,421.34 €67,513,740
18-Sep-26 43,000 €1,432.07 €61,579,216

ASML’s current share buyback program was announced on 28 January 2026. Further details are available on our website.

This regular update of the transactions conducted under the buyback program is to be made public under the Market Abuse Regulation (Nr. 596/2014).

About ASML

ASML is a leading supplier to the semiconductor industry. The company provides chipmakers with hardware, software and services to mass produce the patterns of integrated circuits (microchips). Together with its partners, ASML drives the advancement of more affordable, more powerful, more energy-efficient microchips. ASML enables groundbreaking technology to solve some of humanity’s toughest challenges, such as in healthcare, energy use and conservation, mobility and agriculture. ASML is a multinational company headquartered in Veldhoven, the Netherlands, with offices across EMEA, the US and Asia. Every day, ASML’s more than 44,100 employees (FTE) challenge the status quo and push technology to new limits. ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. Discover ASML – our products, technology and career opportunities – at www.asml.com.

Media Relations contacts
Monique Mols, phone +31 6 528 444 18
Investor Relations contacts
Jim Kavanagh, phone +31 40 268 3938
Pete Convertito, phone +1 203 919 1714
Peter Cheang, phone +886 3 659 6771

        

 

Aspo Plc Investor news 21 September 2026 at 15.00

Invitation to the Capital Markets Day events of future ESL Shipping Group and Telko Group (Aspo) 24 November 2026

The planned partial demerger of Aspo is expected to create two independent, publicly listed companies with clear growth strategies.

Investors and analysts are invited to attend the Capital Markets Day events taking place in Helsinki (Finlandia Bistro) on Tuesday, 24 November 2026. The morning event will focus on Telko Group and the afternoon event on ESL Shipping Group.

  • Telko is a specialized, regionally leading chemicals distributor with significant growth opportunities and focus on specialty chemicals and value-added services.
  • ESL Shipping is a floating infrastructure leader with unique expertise and a strong position in the Bothnian Bay area.


Schedule of the day (EET):

9.00–9.30 Registration for Telko’s Capital Markets Day

9.30–12.00 Telko presentations, Q&A (Webcast)
Rolf Jansson, CEO, Telko
Telko management team

(12.00–13.00 Lunch)

12.30 Registration for ESL Shipping’s Capital Markets Day

13.00–15.30 ESL Shipping presentations, Q&A (Webcast)
Matti-Mikael Koskinen, Managing Director, ESL Shipping
ESL Shipping management team

Both events can also be followed via a live webcast. The recording of the event and the presentation material will be available after the event at aspo.com.

The venue of the onsite event is: Karamzininranta 4 (K2 door), Helsinki.

Registration

More information and the registration form will be available at aspo.com closer to the event date.

Both events are open also to pre-registered private investors. Please note that Aspo reserves the right to limit in-person attendance due to venue capacity constraints, if necessary.

More information

Aspo’s partial demerger is conditional upon approval by the Extraordinary General Meeting, which is expected to be held on 7 December 2026. Read more about the planned partial demerger.

For further information please contact:

Susanna Hietanen, Communications Director, Aspo Plc, susanna.hietanen@aspo.com, tel. +358 50 3595 701

Aspo creates value by owning and developing business operations sustainably and in the long term. Aspo’s businesses – ESL Shipping and Telko – enable future-proof, sustainable choices for customers in various industries. Established in 1929, today we are together about 650 experts on land and at sea. While the Nordic region is our core market, we serve our customers with world-class solutions in 18 countries around Europe and parts of Asia.

Aspo is listed on Nasdaq Helsinki and is headquartered in Finland.

Aspo – Sustainable value creation

LOUISVILLE, Ky., Sept. 21, 2026 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or “the Company”) announced today that the Company will release third quarter 2026 financial results after the market closes on Wednesday, October 28, 2026, and host a related conference call to discuss the quarter on Thursday, October 29, 2026, at 9 a.m. ET.

Investors and other interested parties may listen to the call by accessing the online, real-time webcast at https://ir.churchilldownsincorporated.com/events-presentations or by registering in advance via teleconference here. Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call. All participants are encouraged to dial-in 15 minutes prior to the start time. An online replay of the call will be available at https://ir.churchilldownsincorporated.com/events-presentations by noon ET on Thursday, October 29, 2026.

A copy of CDI’s news release announcing quarterly results and relevant financial and statistical information about the period will be accessible at http://www.churchilldownsincorporated.com.

About Churchill Downs Incorporated

Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) has created extraordinary entertainment experiences for over 150 years, beginning with the Company’s most iconic and enduring asset, Churchill Downs Racetrack, the home of the Kentucky Derby and premier races of the Thoroughbred Championship Series. Headquartered in Louisville, Kentucky, CDI has expanded through the acquisition, development, and operation of live and historical racing entertainment venues, the growth of the online wagering businesses, and the acquisition, development, and operation of regional casino gaming properties. www.churchilldownsincorporated.com

Investor Contact: Sam Ullrich
(502) 638-3906
Sam.Ullrich@kyderby.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.